Relative Value Partners Group, LLC Chembio Diagnostics, Inc. Transaction History

Relative Value Partners Group, LLC

  • $751 Million
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 12, 2021
SELL
$2.88 - $5.64 $40,294 - $78,909
-13,991 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$4.11 - $7.51 $57,503 - $105,072
13,991 New
13,991 $66,000

About CHEMBIO DIAGNOSTICS, INC.

CEMI Quotes by TradingView
  • Ticker CEMI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,224,600
  • Description
  • Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...
More about CEMI
Track This Portfolio

Track Relative Value Partners Group, LLC Portfolio

Follow Relative Value Partners Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Relative Value Partners Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Relative Value Partners Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email